CanSino Biologics Inc. (HKG: 6185)
Hong Kong
· Delayed Price · Currency is HKD 26.00
-0.10 (-0.38%)
Oct 10, 2024, 4:08 PM HKT
CanSino Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 10,660 | 12,491 | 27,690 | 66,111 | 74,412 | 13,125 | Upgrade
|
| Market Cap Growth | -43.46% | -54.89% | -58.12% | -11.16% | 466.94% | - | Upgrade
|
| Enterprise Value | 9,217 | 10,588 | 23,868 | 58,920 | 68,404 | 12,289 | Upgrade
|
| Last Close Price | 26.00 | 23.55 | 66.75 | 177.89 | 174.24 | 58.19 | Upgrade
|
| PE Ratio | - | -3.56 | -16.04 | 18.72 | -85.30 | -68.45 | Upgrade
|
| PS Ratio | 9.42 | 31.75 | 23.67 | 12.53 | 2517.38 | 5138.41 | Upgrade
|
| PB Ratio | 1.19 | 2.14 | 3.38 | 6.30 | 10.32 | 7.98 | Upgrade
|
| P/FCF Ratio | -7.57 | -7.47 | -8.37 | 63.60 | -98.17 | -43.27 | Upgrade
|
| P/OCF Ratio | -18.47 | -12.48 | -13.23 | 26.27 | -179.06 | -76.07 | Upgrade
|
| EV/Sales Ratio | 13.52 | 26.92 | 20.41 | 11.16 | 2314.14 | 4810.97 | Upgrade
|
| EV/EBITDA Ratio | -7.56 | -6.48 | -16.01 | 25.96 | -115.49 | -53.61 | Upgrade
|
| EV/EBIT Ratio | -5.90 | -5.58 | -14.08 | 26.91 | -111.27 | -50.41 | Upgrade
|
| EV/FCF Ratio | -9.13 | -6.33 | -7.21 | 56.68 | -90.25 | -40.51 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.51 | 0.37 | 0.16 | 0.02 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 0.74 | - | - | Upgrade
|
| Debt / FCF Ratio | -2.34 | -1.78 | -0.92 | 1.62 | -0.22 | -0.62 | Upgrade
|
| Asset Turnover | 0.07 | 0.03 | 0.09 | 0.46 | 0.01 | 0.00 | Upgrade
|
| Inventory Turnover | 1.19 | 1.55 | 1.57 | 2.48 | 0.16 | 0.03 | Upgrade
|
| Quick Ratio | 2.21 | 1.86 | 2.33 | 2.78 | 12.54 | 6.48 | Upgrade
|
| Current Ratio | 2.41 | 2.02 | 2.64 | 3.25 | 13.24 | 6.82 | Upgrade
|
| Return on Equity (ROE) | -16.60% | -31.40% | -12.22% | 26.09% | -10.52% | -15.89% | Upgrade
|
| Return on Assets (ROA) | -6.49% | -10.36% | -8.03% | 11.98% | -7.58% | -10.56% | Upgrade
|
| Return on Capital (ROIC) | -7.49% | -12.01% | -9.43% | 13.82% | -8.24% | -11.90% | Upgrade
|
| Earnings Yield | -12.19% | -13.08% | -3.71% | 3.55% | -0.63% | -1.34% | Upgrade
|
| FCF Yield | -13.22% | -13.39% | -11.95% | 1.57% | -1.02% | -2.31% | Upgrade
|
| Dividend Yield | 0.00% | - | - | 0.55% | - | - | Upgrade
|
| Payout Ratio | 0.00% | - | - | 0.74% | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.38% | 0.17% | 0.08% | -7.26% | -11.79% | -34.83% | Upgrade
|
| Total Shareholder Return | 0.38% | 0.17% | 0.08% | -6.70% | -11.79% | -34.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.